Invited speakers

Dr Richard Anderson

Undergraduate training in medicine was punctuated by PhD in MRC Brain Metabolism Unit in neuroendocrinology with George Fink. Subsequently trained in Obstetrics and Gynaecology in Edinburgh, with interest in reproductive endocrinology fostered by WHO Research Fellow post in Hormonal Male Contraception. After completing Subspecialty training in Reproductive Medicine as a lecturer with David Baird at the University of Edinburgh and a year in Sam Yen’s lab in San Diego I returned to the MRC Human Reproductive Sciences Unit in 1998 with a consultant post in Reproductive Endocrinology and Infertility at the Royal Infirmary of Edinburgh. Subsequently appointed to current post in the University in 2005: over recent years I have established a group investigating female reproductive lifespan, with laboratory and clinical aspects particularly related to the adverse effects of cancer treatment on fertility.

Professor Christopher LR Barratt

Christopher Barratt is a Professor of Reproductive Medicine and the Head of the Reproductive and Developmental Biology Group at the University of Dundee, Scotland, and a clinical scientist with NHS Tayside. He is the external examiner for the MSc in Reproductive and Developmental biology at the University of Edinburgh, and an honorary Professor at the Medical School, University of Birmingham, UK. He was a member of the WHO Male Fertility Semen Analysis Taskforce and is now director of the new WHO Male Fertility Expert Working Group which is devising a new system for the diagnosis and treatment of the infertile male. He was also a member of the Human Fertilisation and Embryology Authority for 8 years. Christopher has authored or co-authored 170 original scientific articles in peer reviewed journals, edited eight research books and written 16 chapters in research books and textbooks. He is the Deputy Editor in Chief of Molecular Human Reproduction and has previously been an Editorial Board Member of Human Reproduction, Human Reproduction Update, Biology of Reproduction, Human Fertility and The Journal of Andrology. His life’s ambition is to see Wales beat the All Blacks!

Dr Julian Barth

Julian Barth is Consultant in Chemical Pathology and Metabolic Medicine at Leeds Teaching Hospitals. He qualified at St Bartholomew’s Hospital in London. After training in dermatology and gaining an MD on studies of the effect of androgens on the skin, he changed to a career in laboratory medicine. He currently directs the Leeds SAS Steroid Centre. He is a past editor-in-chief of the Annals of Clinical Biochemistry and past President of the Association of Clinical Biochemistry. His main research interests are in the laboratory diagnostics of endocrinology and acute coronary syndromes.

Dr Graham H Beastall

Dr Graham Beastall obtained his PhD in Steroid Biochemistry from the University of Liverpool. He moved to Glasgow as a University Lecturer before becoming an NHS clinical biochemist. Immediately prior to leaving the NHS in 2009, he was Consultant Clinical Scientist and Clinical Lead for the large multi-site Department of Clinical Biochemistry in North Glasgow. Graham currently works for the UK Government Department of Health as a professional advisor in the life sciences, responsible for curriculum development for healthcare science. He has published more than 175 peer reviewed original articles, mainly in biochemical endocrinology and evidence based laboratory medicine, and given more than 50 invited plenary lectures around the world. Graham has held numerous representative roles, including Chair of the UK NEQAS Steering Committee for Clinical Chemistry, Chair, then President, of the Association for Clinical Biochemistry and Vice President of the Royal College of Pathologists. He has served as President of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) since 2009.

Dr Richard Body

Richard Body is a consultant in Emergency Medicine at Central Manchester University Hospitals NHS Foundation Trust and an honorary lecturer at the University of Manchester. His major research interest is in the early diagnosis of acute coronary syndromes in the Emergency Department, particularly focusing on novel biomarkers including high sensitivity troponin, and their combination with clinical features. Dr. Body currently leads Manchester EMERGING (Emergency and Intensive Care Research Group) and is a founder member of the international CHEST PAIN ('CHest pain Evaluation and Safe Triage Predictive Algorithm International Network') collaborative.

Dr Chris Burns

Dr Chris Burns obtained his PhD from King's College London and worked as a Wellcome Trust post-doctoral research associate at King's before the award of a travelling fellowship took him to the University of Melbourne in Australia. He returned to King's as a Fellow and then took up the post of principal scientist at the National Institute for Biological Standards and Control (NIBSC) in 2005. He has held a visiting lecturer position at King's and is a member of a number of international committees relating to the fields of Endocrinology, Biological Standardisation and Medicines Safety. Chris currently heads the Endocrinology Section at NIBSC and is responsible for the production of International Standards, the testing of biological medicines and a programme of related research.

Dr Graham Carter

Dr Graham Carter started his professional career as a medical laboratory technician in the Royal Cornwall Hospital. After obtaining an MSc in clinical biochemistry at the University of Surrey (1972) he moved to London's Charing Cross Hospital as a Senior Biochemist in the Endocrine Laboratory. He was appointed Consultant Clinical Scientist in 1991 and remained in this post until his retirement from full time employment in September 2000. He was appointed an Honorary Research Fellow at Imperial College in 2001 and continues to organise DEQAS, the international External Quality Assessment Scheme for vitamin D metabolites. The scheme now has over 1200 participants in about 45 countries. Graham is currently serving on a committee set up by the US Office of Dietary Supplements to harmonise 25-hydroxyvitamin D results from national diet and nutrition surveys.

Dr Shiao Chan

Dr Shiao Chan is a Senior Clinical Lecturer in the School of Clinical and Experimental Medicine, University of Birmingham. She is also a practicing Consultant Obstetrician who heads the Endocrine Antenatal Clinic at the Birmingham Women’s NHS Foundation Trust. She graduated in Medicine from the University of Cambridge in 1995 and completed a PhD in 2004 as a Medical Research Council Clinical Training Fellow. She was then funded on a prestigious 5-year Health Foundation Clinician Scientist Fellowship. She has established a research group investigating thyroid hormone action in the fetal brain and placenta, and is also involved in clinical studies of maternal thyroid status and pregnancy outcomes.

Dr Paul Collinson

Dr Paul Collinson studied at St Catharines College, Cambridge (Medicine and Biochemistry) and St Thomas Hospital, London. After an eclectic career path, he is currently Consultant at St George’s Hospital, London. Paul’s doctoral thesis was on the early diagnosis of AMI, with subsequent work on the pathogenesis, diagnosis and management of acute coronary syndromes. A special interest of Paul’s is the cost economics of cardiac care and point of care testing. He has performed two prospective RCT’s on point of care testing and published over 200 papers and review articles, over 220 abstracts and 15 book chapters. Paul likes scuba diving and photographing sharks, especially the ones with big teeth!

Professor John Connell

John Connell is Head of College of Medicine, Dentistry and Nursing, Vice Principal for Research, and Professor of Endocrinology at the University of Dundee. He trained in Medicine at the University of Glasgow, graduating in 1977. In 1983 he joined the MRC Blood Pressure Unit in the Western Infirmary as a clinical scientist and from 1986 to 1987 was MRC Travelling Fellow at the Howard Florey Institute of Experimental Physiology and Medicine in Melbourne, Australia. He was made Honorary Professor at the University of Glasgow in 1994, Professor of Endocrinology in 1996, and Head of the Graduate School of the Faculty of Medicine in the University of Glasgow in 2008. A Fellow of the Academy of Medical Sciences, and Royal Society of Edinburgh, he has also been on the Council of the Society for Endocrinology.

John has a longstanding interest in the regulation of adrenal corticosteroids and their role in cardiovascular disease. His work focuses on the genes that control the late stages of synthesis of aldosterone and cortisol and how variation in these genes might predispose to cardiovascular risk. Author of more than 250 peer reviewed articles, he was awarded the Croonian Lectureship of the Royal College of Physicians in 2004 and the Society for Endocrinology Medal in 200,5 and was the Clinical Endocrinology Trust Lecturer in 2008.

Until recently Dean of the School of Medicine at the University of Dundee, John has a close interest in the development of new teaching methods. Currently on the Steering Committee of the Scottish Clinical Research Excellence Development Scheme for trainee clinical academics, he has chaired the Board of Examiners for the Endocrinology and Diabetes MRCP examination.

Dr S Michael Crawford

Dr Michael Crawford qualified from Liverpool University in 1975. Whilst working in a research post in Bradford Royal Infirmary, he undertook work in multiple myeloma for his MD thesis. This provoked a lifelong interest in tumour markers which was nurtured in his higher training in medical oncology at Charing Cross Hospital. There he saw how near-perfect a tumour marker human chorionic gonadotrophin is and how hard it is to replicate in common tumours. At the time CA125 was becoming established as a tumour marker in ovarian cancer and he has been interested to see how much can be learned from its behaviour.

His garden and his very tiny sailing boat keep his leisure time occupied.

Professor Colin Dayan

Professor Colin Dayan trained in medicine at University College Oxford, and Guy’s and Charing Cross Hospitals in London, before obtaining a PhD in the immunology of Graves’ Disease. He spent a year as an endocrine fellow at the Massachusetts General Hospital in Boston before completing his specialist training in diabetes and endocrinology as a Lecturer in Bristol. In 2010, he was appointed to the Chair of Clinical Diabetes and Metabolism at Cardiff University School of Medicine and became Director of the Institute of Molecular and Experimental Medicine in 2011. He has interests in translational research in the immunopathology of type 1 diabetes and thyroid disease.

Dr Bill Egner

Dr Bill Egner is a Consultant Immunologist at the Sheffield Teaching Hospitals NHS Trust and an Honorary Senior Clinical Lecturer at the University of Sheffield. While studying Medicine at Bristol in the 1980s he intercalated a BSc in Cellular Pathology and became interested in the clinical science of Immunology. He subsequently underwent post-graduate training in Immunology in Oxford, New Zealand and Cambridge. Bill was awarded a PhD on dendritic cells, set up a Clinical Immunology and Allergy Service in Sheffield, and became Scheme Organiser of the UKNEQAS for Immunology, Immunochemistry & Allergy. He is Director of one of the Immunology Protein Reference Units of the national Specialist Assay Service in Sheffield. Bill has published widely on clinical and laboratory aspects of immunology and allergy and serves on committees and working parties of the Royal Colleges of Physicians, Royal College of Pathologists and professional bodies in Immunology and Allergy.

Professor Bill Fraser

Professor Bill Fraser was born and educated in Glasgow, graduating from Glasgow University with BSc (Hons) MBChB and MD (Hons). He trained in Glasgow’s teaching hospitals before spending time as a consultant/travelling fellow in Canada.

In 1991 he was appointed Senior Lecturer in Chemical Pathology and Head of the Metabolic Bone Disease Unit at the Royal Liverpool University Hospital, promoted to Reader in 1998, Professor in 2001, Head of the Unit of Clinical Chemistry in 2008, and Head of Department of Musculoskeletal Biology in 2010. He was Director of the Masters in Research for Clinical Science from August 2008. He was appointed Professor of Medicine at Norwich Medical School, University of East Anglia in May 2011.

Bill Fraser supervises a very active research group investigating the diagnosis and treatment of metabolic bone disease including osteoporosis and Paget’s Disease of bone. He is on the Editorial Board of several journals, a Director of the Supra Regional Assay Service for bone metabolism and calcium homeostasis, and a Medical Advisor to the National Osteoporosis Society. He was a recent recipient of the ACB Foundation Award and presenter of the John Ireland Lecture.

Dr David Halsall

Dr David Halsall is Consultant Clinical Scientist and Clinical Director of the Department of Clinical Biochemistry at Cambridge University Hospitals NHS foundation trust. He is deputy director of the Hormones Supra-Regional Assay service, which provides specialist biochemical and molecular genetic analysis for the investigation of unusual thyroid function tests. David is currently an NHS East of England Clinical Academic Senior Clinical Fellow.

Dr Brian Houston

Dr Brian Houston is the UK Quality Control and Technical Services manager at Immunodiagnostic Systems Ltd, a manufacturer of immunoassay-based diagnostic products located in the North-East of England. He studied Biochemistry at the University of Glasgow, obtaining a BSc and subsequently his PhD. After a post-doctoral fellowship in the Department of Surgery at Edinburgh University, he moved to the AFRC Poultry Research Centre, one of the precursors of the Roslin Institute. At Roslin his research interests encompassed avian growth endocrinology, Bone Morphogenetic Proteins, and the changes in gene expression during growth plate chondrocyte differentiation. He moved to IDS in 2005, working in R&D for several years before taking on the management of the Technical Services and Quality Control departments.

Mr Brian Keevil

Brian Keevil began training as a Clinical Biochemist at Guys Hospital before moving to the University Hospital of South Manchester in 1983. He was appointed Consultant Clinical Scientist at UHSM in 2000. He has developed a special interest in LC-MS/MS methodology over the past 12 years and using this technique has developed many methods for routine and research use in the laboratory, particularly for therapeutic drugs and steroids. Current research interests include the use of alternative sampling strategies such as dried blood spot sampling for the measurement of drugs and salivary analysis for the measurement of free steroids. He has published more than 90 peer reviewed publications and is an honorary senior lecturer at the University of Manchester.

Mr Finlay MacKenzie

Mr Finlay MacKenzie is Consultant Clinical Scientist and Deputy Director of the Birmingham Quality [UK NEQAS] Department at the Queen Elizabeth Hospital, Birmingham and an Honorary Research Fellow at the University of Birmingham.

He began his EQA career in 1987 with Professor John Ratcliffe, as the Scheme Manager for UK NEQAS for Thyroid Hormones, becoming the Organiser in 1996. Under the direction of David Bullock, he has widened his EQA repertoire into the General Chemistry and Paediatric arenas. He became Organiser for the UK NEQAS for Steroid Hormones in 2010.

As well as working with the Department of Health nationally, Finlay has been active internationally with the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), the World Health Organisation (WHO), British Council, the International Atomic Energy Agency (IAEA) and the International Society for Newborn Screening (ISNS).

Dr Jonathan Middle

Dr Jonathan Middle studied Natural Sciences with Part 2 Biochemistry at Cambridge University, followed by a PhD and postdoctoral work in cancer research at Newcastle upon Tyne and Nottingham Universities respectively. In 1980 he re-trained as a clinical biochemist at the Royal Liverpool Hospital before becoming Organiser for the UK NEQAS for Steroid Hormones at Cardiff in 1987. In 1996 he merged his unit with the UK NEQAS centre at Birmingham, becoming Deputy Director and Quality Manager. He also took on the Organisership of the UK NEQAS for Glycated Haemogobins. He retired in 2010, but remains active on the IFCC Committee for Traceability in Laboratory Medicine, as a member of several CLSI Committees and as Chair of the Association for Quality Management in Laboratory Medicine (AQMLM). He has a strong interest in all aspects of metrology and public engagement with science, which he pursues as a Science, Technology, Engineering and Mathematics (STEM) Network Ambassador for healthcare science.

Dr Nicholas Mills

Dr Nicholas Mills was born in Glasgow and raised in Scotland and North America. He studied Medicine and Pharmacology at the University of Edinburgh, graduating in 2000. He undertook his training at the Western General Hospital and Royal Infirmary in Edinburgh before joining the Centre for Cardiovascular Science at Edinburgh University where he is a British Heart Foundation (BHF) Intermediate Clinical Research Fellow, Senior Lecturer and Consultant Cardiologist. His research interests include vascular injury and repair, acute coronary syndrome and cardiac biomarkers. He was recently awarded a BHF Special Project Grant to undertake a multi-centred trial evaluating a prototype high sensitive troponin I assay.

Dr Gary Myers

Gary Myers, PhD, is Vice President, Programs and Policy for the American Association for Clinical Chemistry (AACC). Prior to joining AACC, Dr. Myers served as Chief, Clinical Chemistry Branch at the United States Centers for Disease Control and Prevention (CDC). During his 33+ year career at CDC he directed programs to improve and standardize the laboratory measurement of biomarkers used to assess chronic disease status, particularly for cardiovascular disease and diabetes. Dr. Myers currently serves as Co-Chair of AACC’s International Program for Harmonization of Clinical Laboratory Results. He serves as Secretary for the Scientific Division of the International Federation of Clinical Chemistry and Laboratory Medicine. Dr. Myers is a member of the National Kidney Disease Education Program’s Laboratory Working Group and also a member of the American Diabetes Association’s Insulin Standardization Working Group. He has also been very active in the Clinical and Laboratory Standards Institute (CLSI) having served as Chair of the Global Advisory Committee and as a member of the CLSI Board of Directors.

Dr. Myers has been a member of AACC since 1989. In 2006 Dr. Myers was the recipient of the AACC's Award for Outstanding Contributions through Service to the Profession of Clinical Chemistry. He served as AACC President in 2007.

Dr Les Perry

Dr Les Perry joined the NHS as a Clinical Scientist in 1979 having obtained his MSc in Steroid Endocrinology at Leeds University in 1977. Starting in the Department of Reproductive Physiology at St Bartholomew’s Hospital, London he was responsible for the development and introduction of ‘in-house’ radioimmunoassays for steroid hormones that provided a clinical and research service to the Endocrinology Department. He obtained his PhD from the University of London in 1987 and FRCPath in 2007. He has published over 100+ peer reviewed papers in steroid endocrinology. His current interests focus on the introduction of LCMS technology into healthcare service delivery.

After more than thirty years at Barts & The London, Les was appointed Consultant Clinical Scientist at Croydon University Hospital Trust in 2012. He is currently a member of the UK NEQAS Steering Committee for Clinical Chemistry, Chair of the UK NEQAS Specialist Advisory Group for Endocrinology and Immunoassay, and the ACB representative on the Society for Endocrinology Clinical Committee.

Mr Alan Reid

Alan Reid is a Clinical Scientist within the Biochemistry Department, South Glasgow, NHS Greater Glasgow & Clyde. His research interests in the use of cardiac biomarkers in acute coronary syndrome and heart failure. Alan was a member of the expert panel for NHS Quality Improvement Scotland Health Technology Assessments for use of troponin in acute coronary syndromes and B-type natriuretic peptides in the investigation of patients with heart failure. In 1997 Alan developed a EQA service for troponin. This has since expanded and includes all the routine cardiac biomarkers in use today.

As Scheme Organiser of the UK NEQAS Cardiac Marker Service, Alan is continuing to develop EQA schemes for both laboratory and point of care systems with current and future cardiac biomarkers. Interpretative exercises are also undertaken to assist participants in clinical interpretation of cardiac biomarker testing.

Dr Cathie Sturgeon

Dr Cathie Sturgeon is Consultant Clinical Scientist and Director of the UK National External Quality Assessment Service (UK NEQAS) unit at the Royal Infirmary of Edinburgh and Honorary Senior Lecturer at the University of Edinburgh. She is currently Vice-Chair of the group developing National Academy of Clinical Biochemistry (NACB) Laboratory Medicine Practice Guidelines for the use of tumour markers in the clinic and Chair of the IFCC Working Group for PTH. Cathie has a long-standing interest in working to improve the appropriate use and comparability of laboratory results. These activities are facilitated by excellent and much appreciated collaboration with many colleagues.

Professor Linda Thienpont

Professor Linda Thienpont is Director of the Mass Spectrometric Reference Laboratory at Ghent University. Her main scientific interest is standardization in laboratory medicine and she has developed and validated reference measurement procedures for substrates, total and free steroid and thyroid hormones, and peptides. She has over 140 publications in this field. Linda has participated as Chair and/or member in many projects organized by professional organizations including BCR, IRMM-JRC, CEN-TC 140, IFCC, JCTLM, AACC, ODS/NIH, and CDC. She is a member of the Editorial Board of Clinical Chemistry and in 2011 was recipient of the IFCC-Robert Schaffer Award for Outstanding Achievements in the Development of Standards for Use in Laboratory Medicine.

Professor Peter Trainer

Professor Peter Trainer received his undergraduate training in Edinburgh and his post-graduate training in London, Utrecht and Portland, Oregon. He has been a consultant endocrinologist at the Christie Hospital since 1998, having previously been a senior lecturer in endocrinology at Saint Bartholomew’s Hospital Medical School in London. His areas of research include pituitary and adrenal disease, particularly Cushing’s syndrome and acromegaly.

Peter is an active leader in the medical community within the Christie Hospital, as well as nationally and internationally, serving on the senior executive committees of the UK, American and European Societies for Endocrinology. He chaired the clinical programme of the American Endocrine congress in 2007 and programme organizing committee for the European Congress of Endocrinology in 2011.

Peter has published over 150 peer-reviewed papers and is a much sought after lecturer and teacher. He has served on the editorial boards of Journal of Clinical Endocrinology and Metabolism, Clinical Endocrinology, Treatments in Endocrinology, and GH and IGF Research.

Dr Hubert Vesper

Hubert W. Vesper, PhD is the Director of Clinical Standardization Programs at the Center for Disease Control and Prevention (CDC). He works on projects aimed at improving laboratory measurements used for the diagnosis, treatment and prevention of chronic diseases. Dr. Vesper is leading the CDC clinical reference laboratory and standardization programs for analytes such as cholesterol and steroid hormones. He is an advisor and consultant to organizations dealing with improving and standardizing clinical laboratory measurements such as the National Glycohemoglobin Standardization Program, CLSI Consensus Committee on Clinical Chemistry and Toxicology, CAP Chemistry Resource Committee and ISO TC 212 Working Group 2.

Dr Gwen Wark

Dr Gwen Wark initially studied 'Experimental Pathology and Biochemistry' at St Andrew's University before commencing her PhD studies jointly between the Leukaemia Research Fund Unit, UMIST & Paterson Institute of Cancer Research, Manchester. Her PhD investigated the 'Molecular mechanisms regulating haemopoietic growth and differentiation'. Both degree and PhD involved liaison with hospital laboratories, which encouraged her to put her knowledge and skills to use as a clinical scientist. After training as a clinical biochemist at Guy's and St Thomas' Hospitals where she gained specialist endocrine assay experience, she was appointed in May 1999 as a senior clinical biochemist at the Royal Surrey County Hospital where she is now employed as a consultant clinical scientist. Her duties are principally within the Supra-regional Assay Service (SAS) Peptide Hormones Laboratory which specialises in the investigation of hypoglycaemia where she is now Director. During the previous years, she has also participated in all aspects of the UK NEQAS Guildford Peptide Hormones Scheme (which includes the analytes: insulin, C-peptide, gastrin, IGF-I and IGFBP-3) and became scheme organiser in 2002.

Her research interests complement many of the activities of the UK NEQAS scheme as she studies the use of diagnostic tests for the investigation of spontaneous hypoglycaemia and the role of insulin-like growth factors and their binding proteins.

Dr Davinia White

Dr Davinia White was born and raised in New Zealand. After completing a Fellowship in General Medicine she joined the research group of Prof Stephen Franks. Research where her research focussed on LH hypersecretion and genetic basis of PCOS. Subsequently took up a clinical post in the Reproductive Endocrine and Fertility service at St Mary’s Hospital, Imperial College Healthcare Trust and is now lead clinician in the fertility service and directs the ovulation induction programme.

Dr Ingrid Zegers

Dr Ingrid Zegers graduated in Chemistry at the Vrije Universiteit Brussel (VUB). For her Masters thesis she worked on protein-nucleotide interactions. During her PhD and postdoctoral activities, she studied the structure, function and physical chemistry of macromolecules involved in bacterial heavy metal resistance. Since 2006 she has worked at the European Commission Joint Research Centre (Institute for Reference Materials and Measurements), which, in collaboration with the IFCC, develops reference materials for clinical markers. Ingrid is responsible for the Biochemistry Laboratory, which focuses on the standardisation of the measurement of complex proteins and the production of suitable protein reference materials.